Eculizumab-related progressive multifocal leukoencephalopathy

Neurology

Volumn 86, Issue 4, 2016, Pages 399-400

  Gómez Cibeira, Emilio ^a   Ivanovic Barbeito, Yerko ^a   Gutiérrez Martínez, Eduardo ^a   Morales, Enrique ^a   Abradelo, Manuel ^a   Hilario, Amaya ^a   Ramos, Ana ^a   Ruiz Morales, Juan ^a   Villarejo Galende, Alberto ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ECULIZUMAB; EVEROLIMUS; GADOLINIUM; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; MONOCLONAL ANTIBODY;

ADULT; ANEMIA; ATAXIA; BRAIN DAMAGE; CASE REPORT; CEREBELLUM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DIPLOPIA; DISEASE COURSE; DNA DETERMINATION; DNA VIRUS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; HEMISPHERE; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMAGE ENHANCEMENT; LIMB WEAKNESS; LYMPHOCYTE COUNT; NEUTROPHIL COUNT; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RELAPSE; SPASTICITY; UNSTEADY GAIT; VIRUS DETECTION; WHITE MATTER LESION; ATYPICAL HEMOLYTIC UREMIC SYNDROME; INTESTINE; JC VIRUS; KIDNEY TRANSPLANTATION; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHANGIECTASIS, INTESTINAL; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; TRANSPLANTATION; VIROLOGY;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ATYPICAL HEMOLYTIC UREMIC SYNDROME; FEMALE; HUMANS; INTESTINES; JC VIRUS; KIDNEY TRANSPLANTATION; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHANGIECTASIS, INTESTINAL;

EID: 84956764057     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002312     Document Type: Note

References (7)

1. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010; 9: 425-437.
2. Parker C. Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet 2009; 373: 759-767.
3. Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 2013; 80: 1430-1438.
4. Berger JR, Houff SA, Major EO. Monoclonal antibodies and progressive multifocal leukoencephalopathy. MAbs 2009; 1: 583-589.
5. Yousry TA, Pelletier D, Cadavid D, et al. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 2012; 72: 779-787.
6. Stoerner KA, Morrison TE. Complement and viral pathogenesis. Virology 2011; 411: 362-373.
7. Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 2012; 366: 1870-1880.